2026 Q2 Portfolio Activity
In 2026 Q2, Samsara BioCapital, LLC maintained a portfolio of 26 distinct positions. The most significant new addition was ARTIVA BIOTHERAPEUTICS INC, now representing 0.76% of the total fund value. They heavily accumulated shares in ALAMAR BIOSCIENCES INC, increasing the position by 313.4%. The fund also reduced its exposure to SPYGLASS PHARMA INC by 81.0%.
Position History
hover any row below to update
Loading…
Total Positions
26
Quarter
2026 Q2
Top Holding
SRRK (31.2%)
Top 10 Concentration
90.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-26 of 26
Samsara BioCapital, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 31.16% | 32.95% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
6,897,652 | $379,370,860 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALMS
ALUMIS INC
|
Healthcare | 14.67% | 13.58% |
#2
1
Prev: #3
|
6.5 |
—
|
no change | no change |
P
S
|
6,345,219 | $178,554,463 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 13.01% | 15.45% |
#3
1
Prev: #2
|
6.0 |
—
|
no change | no change |
P
S
|
5,871,018 | $158,400,066 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SEPN
SEPTERNA INC
|
Healthcare | 8.66% | 7.35% |
#4
Prev: #4
|
5.0 |
—
|
no change | no change |
P
S
|
3,149,128 | $105,464,297 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ALAMAR BIOSCIEN...
|
|
Unknown | 5.52% | — |
#5
Prev: #—
|
6.2 |
—
|
2,480,310 | — |
NEW
|
2,480,310 | $67,191,598 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
NGNE
NEUROGENE INC
|
Healthcare | 4.44% | 3.36% |
#6
1
Prev: #7
|
2.8 |
—
|
no change | no change |
P
S
|
1,717,127 | $54,003,644 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KLRS
KALARIS THERAPE...
|
Healthcare | 4.31% | 7.26% |
#7
2
Prev: #5
|
2.2 |
—
|
-66,906 | -0.5% |
P
S
|
12,881,175 | $52,426,382 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
SPYGLASS PHARMA...
|
|
Unknown | 3.86% | 5.31% |
#8
2
Prev: #6
|
2.5 |
—
|
no change | no change |
P
S
|
2,109,953 | $46,967,554 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 2.90% | 2.57% |
#9
Prev: #9
|
2.2 |
—
|
no change | no change |
P
S
|
1,062,872 | $35,287,350 | 2018 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IVA
INVENTIVA SA
|
Healthcare | 1.96% | 2.80% |
#10
2
Prev: #8
|
3.3 |
—
|
1,120,000 | 21.6% |
P
S
|
6,314,805 | $23,869,963 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 1.34% | 1.32% |
#11
1
Prev: #10
|
0.5 |
—
|
-232,561 | -24.0% |
P
S
|
736,237 | $16,359,186 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
PARABILIS MEDIC...
|
|
Unknown | 1.25% | — |
#12
Prev: #—
|
4.0 |
—
|
556,044 | — |
NEW
|
556,044 | $15,218,924 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
VTVT
VTV THERAPEUTIC...
|
Healthcare | 0.92% | 1.15% |
#13
2
Prev: #11
|
1.4 |
—
|
no change | no change |
P
S
|
298,496 | $11,238,374 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AQST
AQUESTIVE THERA...
|
Healthcare | 0.85% | 1.01% |
#14
2
Prev: #12
|
1.3 |
—
|
no change | no change |
P
S
|
2,500,000 | $10,400,000 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NKTX
NKARTA INC
|
Healthcare | 0.82% | 0.72% |
#15
1
Prev: #14
|
1.3 |
—
|
no change | no change |
P
S
|
3,507,666 | $9,926,695 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARTV
ARTIVA BIOTHERA...
|
Healthcare | 0.76% | — |
#16
Prev: #—
|
3.8 |
—
|
954,861 | — |
NEW
|
954,861 | $9,262,152 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RANI
RANI THERAPEUTI...
|
Healthcare | 0.65% | 0.61% |
#17
2
Prev: #19
|
2.8 |
—
|
1,869,159 | 22.0% |
P
S
|
10,369,159 | $7,884,709 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
AGOMAB THERAPEU...
|
|
Unknown | 0.64% | 0.61% |
#18
Prev: #18
|
1.3 |
—
|
no change | no change |
P
S
|
600,000 | $7,788,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ABVX
ABIVAX SA
|
Healthcare | 0.60% | 0.61% |
#19
2
Prev: #17
|
0.7 |
—
|
-1,486 | -2.6% |
P
S
|
55,095 | $7,341,960 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XFOR
X4 PHARMACEUTIC...
|
Healthcare | 0.54% | 0.74% |
#20
7
Prev: #13
|
0.2 |
—
|
-436,979 | -23.8% |
P
S
|
1,395,587 | $6,517,391 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ELOXX PHARMACEU...
|
|
Unknown | 0.46% | — |
#21
Prev: #—
|
3.7 |
—
|
400,000 | — |
NEW
|
400,000 | $5,552,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
CHRS
COHERUS ONCOLOG...
|
Healthcare | 0.39% | 0.56% |
#22
2
Prev: #20
|
1.2 |
—
|
no change | no change |
P
S
|
3,428,571 | $4,799,999 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UPB
UPSTREAM BIO IN...
|
Healthcare | 0.20% | 0.64% |
#23
7
Prev: #16
|
0.1 |
—
|
-382,330 | -51.9% |
P
S
|
353,717 | $2,447,722 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GOSS
GOSSAMER BIO IN...
|
Healthcare | 0.10% | 0.23% |
#24
2
Prev: #22
|
1.0 |
—
|
no change | no change |
P
S
|
7,222,559 | $1,188,833 | 2019 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 0.00% | 0.47% |
Sold All 😨
(Was: #21) |
0.0 |
—
|
-38,432 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACLX
ARCELLX INC
|
Healthcare | 0.00% | 0.68% |
Sold All 😨
(Was: #15) |
0.0 |
—
|
-60,873 | -100.0% |
CLOSED
|
— | $— | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-26 of 26 holdings